CIMT (Carotid Intima-Media Thickness)

Cardiovascular

Vascular Imaging

Carotid intima-media thickness (CIMT) is an ultrasound measurement of the combined thickness of the two inner layers of the carotid artery wall. Because thickening is one of the earliest structural signs of atherosclerosis, a preventive practice uses CIMT to detect vascular aging years before symptoms or events occur.

What It Measures

Ultrasound measurement of carotid artery wall thickness; subclinical atherosclerosis marker

Optimal vs. Lab Range

Longevity Optimal

<75th percentile for age

Target range for optimal health and longevity based on research.

Standard Lab

Age/sex-dependent reference

Population-based reference range from standard labs.

Why It Matters

CIMT measures the combined thickness of the intima and media layers of the carotid artery — an early structural marker of subclinical atherosclerosis that predicts stroke and cardiovascular events years before symptoms appear.

When Low

Generally favorable when thin

When High

Subclinical atherosclerosis, stroke risk, plaque presence

How to Optimize

Reverse or slow progression with Mediterranean-style diet, regular aerobic and resistance training, LDL/ApoB reduction, blood pressure optimization (<120/80), glycemic control, omega-3s, and smoking cessation.

Key Interventions & Linked Compounds

Moderate evidence

Key Interventions

Lipid management

blood pressure control

anti-inflammatory

Linked Compounds & Supplements

Omega-3

Vitamin K2

Aged garlic extract

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Every 2–3 years

Reporting unit

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift CIMT (Carotid Intima-Media Thickness).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.